Skip to content
Go Back

Written by: Medical Affairs Team

Length: 6 minute read

Posted:

  • Immune Function

Understanding Jarisch-Herxheimer Reaction

Jarisch-Herxheimer Reaction

Allison Sayre, MSN, WHNP-BC

Jarisch-Herxheimer Reaction (JHR), otherwise known as a Herxheimer reaction or simply “Herx,” is a transient immunological phenomenon that most commonly occurs after the initiation of antimicrobial treatment in patients infected by spirochetes, a gram-negative bacteria, such as those that cause Lyme disease.[1] Despite being outlined over a century ago, modern medicine has yet to fully understand the intricate interactions of its underlying pathophysiological mechanisms. It has also struggled to provide an effective preventative or therapeutic treatment strategy, leaving patients to deal with the troublesome and uncomfortable side effects.

In this article, we will discuss Jarisch-Herxheimer Reaction along with its pathophysiology, the types of patients who are most prone to this reaction, and how this knowledge can inform clinical practice and improve patient outcomes.

What Is Jarisch-Herxheimer Reaction?

So, let’s start with some history. Jarisch-Herxheimer Reaction was first described in 1895 by Austrian physician Adolf Jarisch, and again in the early 1990’s by German physician Karl Herxheimer, after both described similar adverse reactions in patients being treated for syphilis. It has since been recognized in a wide variety of infectious diseases, especially those caused by spirochetes, such as Lyme disease (Borrelia burgdorferi), Tick-borne relapsing fever (multiple Borrelia species), and leptospirosis (Leptospira). [1][2]

The Jarisch-Herxheimer Reaction is an acute inflammatory response that is typically seen within the first few hours to days after antimicrobial therapy begins and is characterized by a temporary, yet often uncomfortable, exacerbation of symptoms such as fever, chills, muscle pain, rash, headache, and fatigue. These symptoms can be alarming to patients and are often mistaken for an allergic reaction to antibiotic therapy or a worsening of the disease being treated, when in reality, the symptoms represent the body’s reaction to dying microorganisms. [1]

What is the Pathophysiology behind the Jarisch-Herxheimer Reaction?

The exact mechanism behind the Jarisch-Herxheimer Reaction is still not fully understood. While researchers have proposed various theories, the most widely accepted explanation points to the release of endotoxins from dying microorganisms. When these pathogens die rapidly in response to antibiotics or other antimicrobial agents, they release their intracellular contents, including lipoproteins and other cell wall components. This release sparks a cascade of immune responses, particularly through the activation of pro-inflammatory cytokines such as TNF-α, IL-6, and IL-8.[1][2]

This inflammatory response leads to symptoms commonly associated with JHR, such as fever, rash, chills, and flu-like symptoms. The cytokine surge that occurs is thought to result in increased vascular permeability, which can cause fluid shifts and an exacerbation of symptoms, such as edema and hypotension. Cytokine surges can be thought of as a mild version of a cytokine storm. In certain cases, the reaction can lead to tissue damage and exacerbation of pre-existing symptoms, like joint pain, or neurological manifestations such as psychoses, convulsions, or focal neurological deficits. [1][2]

Which Patients Are Most Prone to Jarisch-Herxheimer Reaction?

While we have learned that a “Herx” reaction most commonly occurs in those undergoing antimicrobial treatment for a spirochete infection, certain individuals may be more susceptible to experiencing this reaction. The following factors can increase the likelihood of a patient experiencing a Herxheimer Reaction:

1. High Microbial Burden 

Individuals with high levels of a pathogen in their system are more prone to JHR. Simply put, the greater the number of microorganisms being killed off by antimicrobial agents, the greater the potential for an inflammatory response. [2]

2. Weakened Immune Systems

Patients with compromised immune systems, such as those with autoimmune diseases, HIV/AIDS, or those who are pregnant or undergoing immunosuppressive treatments, may be at greater risk of developing JHR, as their immune system may be less able to handle the sudden surge of inflammatory mediators.[3]

3. Treatment with Broad-Spectrum Antibiotics

Certain broad-spectrum antibiotics, such as penicillin or cefuroxime, are more likely to induce a reaction, as they can cause a more rapid die-off that triggers the inflammatory response. [2]

What are the Clinical Implications?

 Patient Education and Communication.

One of the key steps in managing JHR is educating patients on the chance of a reaction, as well as what is taking place during a reaction and why. When patients know that the reaction is a normal part of their body’s response to treatment, it can help prevent unnecessary panic. By clearly explaining what the reaction is and why it occurs, practitioners can help ease anxiety and keep patients on track with their treatment. [1]

Prevention.

While prevention is not always possible with JHR, practitioners should take consideration when choosing their choice of antimicrobial therapy, as it can influence the severity of the reaction. Unfortunately, various conventional methods, such as corticosteroids, acetaminophen, opioid antagonists, and anti-cytokine drugs have shown inconsistent results in preventing reactions. [2]

Diagnostic Testing.

JHR is typically clinically diagnosed with a proper history and physical examination. There are no specific diagnostic tests available, however, polymorphonuclear leukocytosis, lymphopenia, and raised erythrocyte sedimentation rate (ESR) have been reported in cases of JHR. [1]

Managing Symptoms. 

Although symptoms are typically self-limiting, they can still be distressing for patients and should not be overlooked. Focusing on inflammation and detoxification seems to be at least theoretically valuable. The following are some integrative strategies that may alleviate discomfort and accelerate recovery. 

·      Staying hydrated. Drinking water is key to preventing dehydration and flushing out toxins.[4] And for an added bonus, include some electrolytes to help support detoxification and maintain fluid balance.

·      Healthy diet. Eat a nutrient-rich, anti-inflammatory diet including fresh fruits, vegetables, and lean proteins. Avoid processed foods, sugar, and alcohol as these things can further exacerbate inflammation.[5]

·      Epsom Salt Bath. Warm Epsom salt (Magnesium sulfate) baths can draw out toxins and soothe muscle aches.[6]

·      Stress Reduction Techniques. There is almost nothing that this can’t help with! Practice techniques such as meditation, deep breathing exercises, and gentle yoga to help mitigate stress on the body.v

·      Don’t overdo it. Ensure adequate rest and avoid overexertion to help the body heal.

In Summary

Jarisch-Herxheimer Reaction, although a bit alarming to patients, can be managed effectively with the right knowledge and approach. Understanding its underlying pathophysiology and identifying those at higher risk can help practitioners manage the reaction effectively. By incorporating patient education, careful symptom monitoring, and a personalized treatment plan, practitioners can help patients navigate this common, though often uncomfortable, therapeutic response.

Disclaimer:

The information provided is for educational purposes only. Consult your physician or healthcare practitioner if you have specific questions before instituting any changes in your daily lifestyle including changes in diet, exercise, and supplement use.

Allison Sayre, MSN, WHNP specializes in women's health and functional medicine, blending both traditional and integrative approaches. With over 17 years of experience, she has empowered women to reclaim their health through personalized nutrition and supplementation, hormone balancing, and lifestyle modifications. She received her Bachelor of Science from Mount Carmel College of Nursing and her Master of Science from the University of Cincinnati. She has been a certified women’s health nurse practitioner since 2014 and has continued her education and training in functional medicine from both the Institute for Functional Medicine as well as the American Academy of Anti-Aging Medicine.

[1] Dhakal A, Sbar E. StatPearls-NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK557820/

[2] Pound MW, May DB. J Clin Pharm Therapeutics.
2005;30(3):291-295. doi:10.1111/j.1365-2710.2005.00631.x

[3] Tsai M, et al. J Int AIDS Soc. 2014;17(1).
doi:10.7448/ias.17.1.18993

[4] Rani J, et al. Enviro Conserv J. 2018;19(1
& 2):183-186. doi:10.36953/ecj.2018.191226

[5] Puga-Olguín A, et al. Receptors. 2025;4(1):5.
doi:10.3390/receptors4010005

[6] Vats S, et al. J Clin Diag Res.2024;18(9).
doi:10.7860/jcdr/2024/72825.19979

Back to all posts

Stay Connected

Sign up and we’ll keep you up to date on the latest news, clinical education resources, product innovations and promotions.